Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arix, Biogen, Bristol Myers Squibb, Daiichi Sankyo, Dynavax Technologies, Excellthera, Gilead Sciences, Janssen, Lexicon, Merck, Passage, Sanofi, Seagen, Soleno, V2act, Viiv Healthcare, Xeris.